🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 16 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/03/2007 14,58 15,12 14,58 14,88 +0,81% 3,70% 94.717
06/03/2007 15,42 15,60 14,28 14,76 -3,15% 8,56% 202.733
05/03/2007 15,00 15,78 15,00 15,24 +1,20% 5,20% 102.467
02/03/2007 15,60 15,84 15,06 15,06 -3,46% 5,00% 95.000
01/03/2007 15,78 16,02 15,54 15,60 -2,26% 3,04% 77.150
28/02/2007 16,44 16,50 15,90 15,96 -2,92% 3,65% 123.133
27/02/2007 17,10 17,16 16,20 16,44 -3,86% 5,61% 106.333
26/02/2007 17,28 17,40 17,04 17,10 -0,70% 2,08% 56.750
23/02/2007 17,58 17,70 17,10 17,22 -2,38% 3,41% 83.333
22/02/2007 17,28 17,70 17,22 17,64 +1,73% 2,78% 60.367
21/02/2007 17,58 17,76 17,10 17,34 -2,03% 3,75% 79.133
20/02/2007 17,46 17,82 17,46 17,70 +0,34% 2,06% 53.550
16/02/2007 17,04 17,70 16,86 17,64 +3,89% 4,93% 72.917
15/02/2007 17,70 17,70 16,92 16,98 -3,41% 4,41% 97.667
14/02/2007 17,88 18,18 17,58 17,58 -1,68% 3,36% 43.533
13/02/2007 17,94 18,00 17,46 17,88 -1,00% 3,01% 65.117
12/02/2007 17,58 18,12 16,92 18,06 +3,79% 6,83% 120.583
09/02/2007 17,76 17,94 17,28 17,40 -2,03% 3,72% 101.017
08/02/2007 18,06 18,24 17,76 17,76 -0,34% 2,66% 70.867
07/02/2007 17,88 18,24 17,64 17,82 -1,00% 3,36% 71.483
06/02/2007 18,24 18,48 17,94 18,00 -0,99% 2,96% 73.417
05/02/2007 18,84 18,90 18,06 18,18 -0,98% 4,46% 125.150
02/02/2007 18,48 18,60 18,24 18,36 +0,00% 1,95% 87.767
01/02/2007 18,18 18,48 18,12 18,36 +0,99% 1,98% 55.133
31/01/2007 18,96 19,26 18,06 18,18 -3,50% 6,33% 123.483
30/01/2007 18,00 18,90 17,88 18,84 +5,02% 5,67% 68.750
29/01/2007 18,06 18,24 17,64 17,94 -0,66% 3,32% 69.750
26/01/2007 18,36 18,36 17,52 18,06 +0,00% 4,58% 82.083
25/01/2007 18,30 18,36 18,00 18,06 -0,33% 1,97% 87.033
24/01/2007 17,46 18,48 17,40 18,12 +3,78% 6,19% 131.250